NEW YORK, July 31, 2024 /PRNewswire/ — In the healthcare sector where Artificial Intelligence (AI) plays a crucial role, Zoi Capital is pleased to introduce the AI Doc Platform, a unique internal tool created to pinpoint high-potential use cases and firms in health AI.
As AI garners increasing importance in healthcare, Zoi Capital is dedicated to investing in the next wave of health AI technologies with a specialized investment approach. Founded by Dr. Ronald M. Razmi, a cardiologist trained at Mayo Clinic, digital health CEO, and the author of “AI Doctor: The Rise of Artificial Intelligence in Healthcare,” Zoi Capital is leading the way in private market investing.
Dr. Razmi, backed by a team of digital health investors and operators, brings a wealth of clinical, operational, and investment expertise. Co-Founders Brian Beeler and Dr. Ronald M. Razmi collectively boast an impressive track record with exits exceeding $30 billion through public markets and acquisitions.
“With sectors like healthcare growing in complexity alongside evolving technologies like AI, achieving high returns on investment and ensuring funding for top-notch use cases and technologies necessitates specialization and focus,” remarked Dr. Razmi.
To establish a scalable and systematic method for assessing AI solutions that tackle crucial healthcare issues, Zoi Capital has developed exclusive scorecards. These scorecards evaluate the use cases targeted by health AI firms and the firms themselves. This approach guarantees the identification of top-priority use cases and firms that effectively navigate adoption challenges.
“The purchasers of these technologies must sift through numerous digital solutions within limited budgets, choosing only those that address their most critical needs,” explained Dr. Razmi. “Identifying these use cases should form the cornerstone of any health AI investment strategy. Once the use cases are identified, locating firms with technologies and business models that resolve technical, clinical, and business hurdles will be crucial.”
Brian Beeler, Zoi Capital’s co-founder, contributed, “In order to usher in a new era of allocating capital to top use cases and firms, careful evaluation by experts will be key to success.”
The AI Doc Platform, Zoi Capital’s comprehensive investment tool, comprises:
- Knowledge Management System: This system segments the healthcare space into 18 sub-sectors, monitoring crucial unmet needs, business trends, and emerging technologies in each segment.
- Comprehensive Database: The database covers thousands of digital health firms, detailing their technologies, addressed use cases, investors, customers, funding, and more.
- ZoiCare Scorecards for Investment Excellence (Z-Six): These scorecards ensure that only the highest-priority use cases for technology buyers are considered for investment and that selected firms tackle the adoption barriers hindering many promising technologies.
This approach guides Zoi Capital’s investment decisions and offers a framework for entrepreneurs to refine and position their innovations successfully in the intricate healthcare realm.
For more information on how Zoi Capital is positioned uniquely to lead the charge as the healthcare sector braces for an AI-induced transformation, feel free to schedule a discussion with Dr. Razmi and/or Brian Beeler.
For further details, visit:Â www.zoicap.com
About Zoi Capital
Zoi Capital is a focused venture capital firm specializing in the growing applications of artificial intelligence in healthcare.
Led by Brian K. Beeler, a former executive in the life sciences industry involved in managing various corporate venture funds and transactions worth over $7 billion, and Dr. Ronald M. Razmi, a former Cardiologist, McKinsey consultant, CEO of Acupera, and author of the book, AI Doctor: The Rise of Artificial Intelligence in Healthcare, the firm’s strengths include diverse expertise in medical practice, successful operation of digital health firms, and investment in medical technologies.
With their proprietary investment platform, AI Doc, Zoi Capital identifies and selects firms with technologies that offer immediate healthcare stakeholder benefits while addressing the unique friction points that often impede or delay adoption. Teaming up with prestigious medical centers provides access to exclusive deal flows, and Zoi actively contributes to enhancing product roadmaps, optimizing commercialization strategies, and expediting exits.
Press Contact: Michelle Moskowitz, 917-597-0863
SOURCE Zoi Capital
